Development of STAT3 dimerization inhibitors for cancers
TS-037569 —
The constant activation of Signal Transducer and Activator of Transcription 3 (STAT3) is frequently detected in many cancer patients with advanced diseases. About 80% of all cancers overexpress STAT3, including solid tumors, lymphoma, and leukemia. Constant activation of STAT3 activities in nonmal…
- College: College of Pharmacy
- Inventors: Li, Pui-Kai "Tom"; Li, Chenglong; Lin, Jiayuh
- Licensing Officer: He, Panqing